Covis Pharma
FDA Forces Unproven Premature Birth Drug Makena Off Market
The decision follows repeated efforts by Swiss drugmaker Covis Pharma to keep Makena on the U.S. market while it conducted additional studies. read more >
FDA Pushes to Remove Pregnancy Drug, Company Pushes Back
Health regulators insist Covis Pharma's product doesn't work. read more >
by Associated Press -
Sign up for Daily E-news
Sign Up
THIS WEEK’S EDITION
This Week’s Stories
View Digital Edition
